Overcoming Barriers to Clinical Research (White Paper)

The largest barrier to conducting clinical research is the high cost. According to the Tufts Center for the Study of Drug Development (CSDD), it now costs up to $2.6 billion to bring a new drug to market, up from $1 billion from the 1990s to the early 2000s, and costs are continuing to rise. In addition, fewer than 12% of the candidate medicines that make it into Phase I clinical trials are approved by the FDA.

Read the entire White Paper